https://www.selleckchem.com/pr....oducts/2-2-2-tribrom
BACKGROUND The clinicopathological and survival profiles across primary sites in acral melanoma (AM) are still controversial and unclear. METHODS This is a multi-center retrospective study. Clinicopathological data of AM patients diagnosed between 1 January 2000 and 31 December 2017 from 6 large tertiary hospitals in China were extracted. Chi square tests were used to compare basic characteristics between primary sites of sole, palm and nail bed. Melanoma-specific survival (MSS) differences based on primary sites were comp
إعجاب
علق
شارك
